CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.
about
Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sitesAtrial fibrillation therapy now and in the future: drugs, biologicals, and ablationmiR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes.Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanismsAltered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808Beta-adrenergic receptor signaling in the heart: role of CaMKII.miRNA in the regulation of ion channel/transporter expression.Transient outward potassium channel: a heart failure mediator.Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers.Dynamic Kv4.3-CaMKII unit in heart: an intrinsic negative regulator for CaMKII activation.Calcium/calmodulin-dependent protein kinase II mediates cardioprotection of intermittent hypoxia against ischemic-reperfusion-induced cardiac dysfunction.Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.The regulatory circuits for hysteretic switching in cellular signal transduction pathways.
P2860
Q24315218-4E41B072-F3DF-4138-8760-1DA612A75B9EQ26864767-3B0DC1CA-C9CA-4B57-927B-6C193BB223A4Q28117385-51D89DD0-5351-4A7E-98DD-4E12E4908658Q28592681-A55F33E9-40F7-4F91-A19F-FA28B0244DDAQ33559348-14ABF549-0F97-40C1-A78B-15C1C1B0C0FAQ33886760-30A81FE9-9B1F-4B5D-9AD1-46C91D6762C8Q36174925-86B05BF4-4B2E-483A-89B0-B4DC2EB24CAAQ36837270-4D71B5ED-8CA0-47C8-BF54-907AD9BC2528Q37114848-9A9FEB00-318F-4550-A55F-6D94F2F496F6Q37120202-8387E3B6-BBB8-4071-9846-7F1125F130D1Q37626164-1B1E018D-C346-417A-A257-9D6BA8B7ED54Q38110520-53594101-95AB-4496-810F-01939553486EQ38342269-17178A3B-ED53-420C-8EAE-BED17F0DBC61Q41867019-1DEBA1CD-B22E-4317-92CD-C6B00B0FDA0EQ41871340-112B22B6-9FDE-4F01-8A97-786D979374CFQ45969824-1E198C0E-A05B-497B-9739-C8ACE883E344Q48325152-0EE8C882-1A7A-471F-AC65-1A53EE14765DQ48527084-F7BE8001-961E-4D23-B0FC-FA2EC77D0D9E
P2860
CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
CaMKII, an emerging molecular ...... mias, and cardiac dysfunction.
@ast
CaMKII, an emerging molecular ...... mias, and cardiac dysfunction.
@en
type
label
CaMKII, an emerging molecular ...... mias, and cardiac dysfunction.
@ast
CaMKII, an emerging molecular ...... mias, and cardiac dysfunction.
@en
prefLabel
CaMKII, an emerging molecular ...... mias, and cardiac dysfunction.
@ast
CaMKII, an emerging molecular ...... mias, and cardiac dysfunction.
@en
P1476
CaMKII, an emerging molecular ...... hmias, and cardiac dysfunction
@en
P2093
Chad E Grueter
Mark E Anderson
P2860
P2888
P356
10.1007/S00109-006-0125-6
P577
2006-11-21T00:00:00Z